Vanguard Group’s Artelo Biosciences ARTL Stock Holding History

Vanguard Group’s Portfolio ARTL Stock Details ARTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$17.1K	Hold	4,676	–	–	﹤0.01%	4311
2025 Q3	$64.4K	Buy	+4,676	New	+$143K	﹤0.01%	4267
2023 Q1	–	Sell	-3,476	Closed	-$181K	–	4556
2022 Q4	$181K	Sell	3,476 -471	-12%	-$24.6K	﹤0.01%	4326
2022 Q3	$245K	Buy	3,947 +1,414	+56%	+$114K	﹤0.01%	4385
2022 Q2	$217K	Hold	2,533	–	–	﹤0.01%	4459
2022 Q1	$308K	Sell	2,533 -767	-23%	-$88.1K	﹤0.01%	4467
2021 Q4	$462K	Buy	3,300 +86	+3%	+$17K	﹤0.01%	4443
2021 Q3	$687K	Buy	3,214 +21	+0.7%	+$5.33K	﹤0.01%	4324
2021 Q2	$1.03M	Buy	3,193 +2,274	+247%	+$777K	﹤0.01%	4143
2021 Q1	$404K	Buy	+919	New	+$393K	﹤0.01%	4165

Other funds holding ARTL

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group's ARTL Position: Q4 2025 in Review

Vanguard Group held its Artelo Biosciences (ARTL) position steady in Q4 2025 at 4,676 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4311.

Vanguard Group first reported a position in ARTL in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.03M in Q2 2021. 8 funds tracked by Wall St. Rank hold ARTL as of Q4 2025.

Vanguard Group held 4,676 shares of Artelo Biosciences worth $17.1K as of Q4 2025.
Vanguard Group left its Artelo Biosciences share count unchanged in Q4 2025.
Artelo Biosciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4311 holding.
Vanguard Group first reported a position in Artelo Biosciences in Q1 2021 and has held it in 10 quarters since.
Vanguard Group's Artelo Biosciences position peaked at $1.03M in Q2 2021.
8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.